Mar 1, 20245 min readFresh Wind Team Unveils Two AI Models for Cancer ImmunotherapyThe interaction between tumor antigens presented by major histocompatibility complex (MHC) and T-cell receptors (TCRs) is essential for...
Aug 21, 20233 min readTEAM FRESH WIND recent publication on TIL therapy clinical application“TEAM FRESH WIND” led by Dr. Satoko Matsueda has recently published a paper tittle as. “Successful ex vivo expansion of tumor...
May 1, 20233 min readWhite House Unveils New Goals to Advance Biotechnology & Biomanufacturing"Bold Goals for U.S. Biotechnology and Biomanufacturing" The White House has announced new goals and priorities to promote biotechnology...
Apr 11, 20233 min readImmune Monitoring ExplainedImmune Monitoring and Breakthrough Immunotherapies More immunotherapies In Feb 2023, FDA granted the “breakthrough therapy designation”...
Mar 24, 20233 min readWhat is TIL Therapy?A cell therapy that may cure cancers The human immune system is extremely complex. When most people think of the immune system, we think...
Feb 19, 20233 min readTIL Therapy with Superior Efficacy Than Immune Checkpoint Inhibitors in Advanced MelanomaNEJM Paper (a Randomized Open-Label Trial) Walkthrough Treating advanced melanoma, a dangerous form of skin cancer, has become a...
Jan 30, 20232 min readIn-Silico Identification of NeoantigensNeoantigens, tumor specific antigens (TSAs), and tumor associated antigens (TAAs) are ultimate targets for cancer immunotherapies....
Jan 19, 20232 min readOrganoids ExplainedLate last year FDA removed the requirements for animal testing before moving into clinical testing. This is a timely move in the right...
Jan 1, 20231 min readTumor Infiltrating LymphocytesTumor infiltrating lymphocytes (TILs) are a type of immune cell that is found within a tumor. Neoantigens are a type of antigen that is...
